EMN
EASTMAN CHEMICAL COMarquee-fund ownership over time
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates re-entered | Q4 2013 | 51Q | $54 | $71 | +30% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $89 | $71 | -20% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $89 | $71 | -20% |
| D.E. Shaw re-entered | Q3 2024(8Q snapshot) | 7Q | $89 | $71 | -20% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $89 | $71 | -20% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $89 | $71 | -20% |
| Renaissance Technologies | Q4 2024(8Q snapshot) | 6Q | $94 | $71 | -25% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Maverick Capital 5× in & out | Q1 2024 | Q2 2024 | → $93 | +24% |
| Duquesne Family Office 2× in & out | Q3 2016 | Q4 2016 | → $54 | +13% |
| Viking Global Investors | Q3 2013 | Q2 2014 | → $58 | +6% |
| JANA Partners | Q3 2013 | Q4 2013 | → $54 | -1% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at EASTMAN CHEMICAL CO. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 3, 2026 — the most recent Form 4 on file — not from today.
- Form 40001977296-26-000005Jun 3, 2026
- Form 40000915389-26-000119May 11, 2026
- Form 40000915389-26-000118May 11, 2026
- Form 40000915389-26-000117May 11, 2026
- Form 40000915389-26-000116May 11, 2026
- Form 40000915389-26-000115May 11, 2026
- Form 40000915389-26-000114May 11, 2026
- Form 40000915389-26-000113May 11, 2026
- Form 40000915389-26-000112May 11, 2026
- Form 40000915389-26-000111May 11, 2026
- Form 40001452301-26-000010May 11, 2026
- Form 40001977296-26-000003May 7, 2026
- Form 40001452301-26-000008Apr 10, 2026
- Form 40000915389-26-000085Apr 10, 2026
- Form 40000915389-26-000084Apr 10, 2026
Fundamentals
XBRL · EASTMAN CHEMICAL COAnnual figures sourced directly from EASTMAN CHEMICAL CO's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for EASTMAN CHEMICAL CO — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-K8-K VOTING RESULTSMay 12, 2026
- 10-QQuarterly reportMay 1, 2026
- 8-KMaterial eventApr 30, 2026
- DEF 14AProxy statementMar 24, 2026
- 8-KMaterial eventFeb 20, 2026
- 10-KAnnual reportFeb 13, 2026
- 8-KMaterial eventJan 29, 2026
- 10-QQuarterly reportNov 4, 2025
- 8-KMaterial eventNov 3, 2025
- 8-KMaterial eventOct 9, 2025
- 10-QQuarterly reportAug 1, 2025
- 8-KMaterial eventJul 31, 2025
- 8-KMaterial eventJun 27, 2025
- 8-KMaterial eventMay 6, 2025
- 8-KMaterial eventMay 5, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Bridgewater Associates | Q1 2026 | open | $79 | $77 | -3% |
| D.E. Shaw | Q4 2025 | open | $59 | $71 | +21% |
| D.E. Shaw | Q2 2025 | Q3 2025 | $77 | $64 | -17% |
| Renaissance Technologies | Q4 2024 | open | $94 | $71 | -25% |
| Citadel Advisors | Q3 2024 | open | $89 | $71 | -20% |
| Two Sigma Investments | Q3 2024 | open | $89 | $71 | -20% |
| D.E. Shaw | Q3 2024 | Q1 2025 | $89 | $95 | +7% |
| AQR Capital Management | Q3 2024 | open | $89 | $71 | -20% |
| Millennium Management | Q3 2024 | open | $89 | $71 | -20% |
| Maverick Capital | Q1 2024 | Q2 2024 | $75 | $93 | +24% |
| Bridgewater Associates | Q3 2023 | Q4 2025 | $76 | $61 | -19% |
| Bridgewater Associates | Q2 2022 | Q4 2022 | $88 | $74 | -16% |
| Maverick Capital | Q4 2021 | Q1 2022 | $97 | $103 | +6% |
| Bridgewater Associates | Q3 2021 | Q4 2021 | $97 | $98 | +1% |
| Bridgewater Associates | Q3 2020 | Q2 2021 | $60 | $108 | +79% |
| Maverick Capital | Q1 2020 | Q2 2021 | $60 | $108 | +82% |
| Maverick Capital | Q3 2019 | Q4 2019 | $50 | $63 | +26% |
| Bridgewater Associates | Q1 2019 | Q2 2020 | $63 | $49 | -22% |
| Maverick Capital | Q3 2018 | Q4 2018 | $75 | $63 | -17% |
| Bridgewater Associates | Q3 2017 | Q4 2017 | $62 | $68 | +10% |
| Duquesne Family Office | Q3 2016 | Q4 2016 | $48 | $54 | +13% |
| Duquesne Family Office | Q3 2015 | Q4 2015 | $54 | $49 | -10% |
| Bridgewater Associates | Q4 2013 | Q1 2017 | $54 | $58 | +7% |
| Viking Global Investors | Q3 2013 | Q2 2014 | $54 | $58 | +6% |
| JANA Partners | Q3 2013 | Q4 2013 | $54 | $54 | -1% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.